A phase I/II study of erlotinib in combination with the anti-insulin-like growth factor-1 receptor monoclonal antibody IMC-A12 (cixutumumab) in patients with advanced non-small cell lung cancer
一项针对晚期非小细胞肺癌患者的厄洛替尼联合抗胰岛素样生长因子-1受体单克隆抗体IMC-A12（西妥昔单抗）的I/II期研究
期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1097/JTO.0b013e31823c5b11
Weickhardt, Andrew; Doebele, Robert; Oton, Ana; Lettieri, Janice; Maxson, DeLee; Reynolds, Michele; Brown, Amy; Jackson, Mary K; Dy, Grace; Adjei, Araba; Fetterly, Gerald; Lu, Xian; Franklin, Wilbur; Varella-Garcia, Marileila; Hirsch, Fred R; Wynes, Murry W; Youssoufian, Hagop; Adjei, Alex; Camidge, D Ross
单克隆抗体
肺癌
肿瘤
肿瘤免疫
信号转导
细胞生物学
免疫/内分泌
